𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Patient and tumor characteristics associated with breast cancer recurrence after complete pathological response to neoadjuvant chemotherapy

✍ Scribed by Na Rae Ju, Donna B. Jeffe, Jason Keune, Rebecca Aft

Book ID
118796799
Publisher
Springer US
Year
2012
Tongue
English
Weight
202 KB
Volume
137
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Metformin and Pathologic Complete Respon
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
✍ Jiralerspong, S.; Palla, S. L.; Giordano, S. H.; Meric-Bernstam, F.; Liedtke, C. πŸ“‚ Article πŸ“… 2009 πŸ› American Society of Clinical Oncology 🌐 English βš– 115 KB

## Purpose Population studies have suggested that metformin use in diabetic patients decreases cancer incidence and mortality. Metformin inhibits the growth of cancer cells in vitro and tumors in vivo. However, there is little clinical data to support this. Our purpose was to determine whether met

MRI evaluation of pathologically complet
MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy
✍ Jeon Hor Chen; Byon Feig; Garima Agrawal; Hon Yu; Philip M. Carpenter; Rita S. M πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 325 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. This study investigated the role of magnetic resonance imaging (MRI) in evaluation of pathologically complete response and residual tumors in patients who were receiving neoadjuvant chemotherapy (NAC) for both positive and negative HER‐2 breast cancer. ## METHODS. Fift